Close menu




February 12th, 2021 | 14:11 CET

Steinhoff, Osino Resources, Sibanye Stillwater- Bargain hunters beware!

  • Investments
Photo credits: pixabay.com

When is a stock cheap? The obvious criterion of a low stock price can sometimes be misleading. For value investors, a stock is cheap when the stock price and intrinsic value are too far apart. Still, other investors "buy" the trend and bet that the movement will continue when the price rises. All approaches have one thing in common: the profit lies in the purchase. We will make you winners!

time to read: 2 minutes | Author: Carsten Mainitz
ISIN: CA68828L1004 , NL0011375019 , ZAE000259701

Table of contents:


    STEINHOFF INTERNATIONAL HOLDINGS NV - next Monday will be exciting!

    The price of the penny stock has doubled since the beginning of the year. The rise occurred, in particular in the wake of speculation that the protracted legal disputes resulting from the massive accounting scandal from 2017 could now be coming to an end.
    However, investors will find out next Monday whether there may still be signs of a setback. A group of investors has asked the competent court in Amsterdam to appoint a new expert to clarify various issues, citing Dutch insolvency law. It is currently impossible to estimate what impact this latest round of legal penalties will have. The Group has at least strongly resisted this step.

    Thus, a lot is going on at Steinhoff - also behind the scenes. Goldman Sachs has secured a 2.8% block of shares recently. There was also an update on the development of the listed South African subsidiary Pepkor, in which Steinhoff holds around 68%. As a result, Steinhoff's stake is currently worth around EUR 2.2 billion. At first glance, the parent company's market capitalization appears very moderate at around EUR 500 million. But the lawsuits of around USD 8 billion floating in the air put the whole thing into perspective. Steinhoff's settlement offer is around USD 1 billion. So it remains very exciting!

    OSINO RESOURCES CORP - important milestones in the next months

    The Canadian gold explorer released further encouraging drill results from the Twin Hills Central Project and the new Clouds Zone in late January. These results show continuing mineralization and near-surface mineralization at the Clouds zone. In addition, the Company announced that it plans to carry out an extensive drilling program of 75,000 meters in the current year. The Canadians plan to release a resource estimate before the end of the first quarter and a prospective economic assessment (PEA) no later than the end of June.

    Osino Resources has focused on acquiring and developing gold projects in Namibia and holds 23 exclusive prospecting licenses covering an area of 6,577 sq km. Namibia is mining-friendly and is considered one of the most stable jurisdictions on the continent, both politically and socially.

    The share has been trading in a corridor of around CAD 1.20 to CAD 1.45 over the last three months. At the latest with the hard facts the Company plans to publish at the end of Q1 and Q2, the share should break out on the upside. With a current market value of CAD 125 million, the Company is by no means overvalued given the project's quality and size.

    SIBANYE STILLWATER LIMITED - 2020 Earnings Exceed Market Expectations

    Sibanye-Stillwater is the largest gold producer in Africa and is among the TOP 3 platinum and palladium producers globally. Last week, the Group published its preliminary figures for the past fiscal year, exceeding market expectations.

    Significantly higher precious metal prices and a weak rand made profits bubble up. According to preliminary calculations, the South African Company achieved a profit for the year of USD 1.75 billion to USD 1.82 billion, corresponding to earnings per share of between USD 0.64 and USD 0.67. Analysts, on average, had expected consolidated revenue of USD 1.7 billion. By comparison, business performance was still very problematic in 2019, resulting in a profit of only USD 4 million.

    Experts expect profits to continue to rise significantly to around USD 3 billion in the current fiscal year. Based on these forecasts, the 2021 P/E ratio is about 4.7, a very moderate valuation level. The stock has more than quadrupled since its low last spring. Nevertheless, analysts see further upside potential of 14% on average in the short term.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read